At BIO Ventures for Global Health (BVGH), we are executing real programs that help biopharmaceutical companies work on products for neglected diseases. We look through the dual lens of the public and private sectors to find the common ground between the goals of global health and the pragmatic needs of companies.
Imagine the effect biotechnology could have on diseases of poverty.
BVGH spurs biopharmaceutical company involvement in global health by:
Designing and advocating for market-based incentives for research and development
BVGH has been deeply engaged in incentives work since its inception, first with the Advance Market Commitment, and then with the Priority Review Voucher. We believe that we must allay some of the financial risk for biopharmaceutical companies in order to bring them in from the sidelines and ensure their involvement in the development of new drugs, vaccines, and diagnostics. You can read more about our incentives work here.
Increasing biopharmaceutical and global health innovator partnerships
Through our Partnering for Global Health Forum, an international partnering conference that brings together leaders from the biopharmaceutical, global health, academic, governmental, non-profit, and funder communities to address the pressing need for new innovation and explore avenues for progress -- as well as our Business Development efforts -- BVGH works to bring together biopharmaceutical and global health innovators. Read more about our partnering work here.
Synthesizing and disseminating critical information and quantitative analyses
BVGH publishes a number of reports each year designed to inform key players about product and market opportunities in global health and draw more companies into global health research and development. Learn more about our publications at the BIO Ventures for Global Health Data Center.
Together these activities move us toward a world where the biopharmaceutical companies who have done so much to revolutionize health care in rich countries are active participants in the effort save the lives of patients in poor countries.